UNC Chapel Hill
The test assigns a pancreatic cancer subtype based on the expression of 16 genes measured using an array.
Researchers plan to continue to test the gene therapy in younger patients based on Phase I data but are hoping to attract a commercialization partner.
Patients Are Dying Waiting for Pluvicto, but Novartis Can't Make More Pending Facility Approval
Premium
Novartis has admitted it underestimated demand for the radiopharmaceutical, though the FDA's approval of a US-based manufacturing facility may provide some relief by summer.
Immune Signatures Outperform TILs for HER2-Positive Breast Cancer Prognoses
Immune-related gene expression signatures tracked more closely with treatment response and outcomes than tumor-infiltrating lymphocytes in early-stage HER2-positive breast cancer.
Inceptor Bio Launches CAR T-Cell-Focused Portfolio Company FastBack Bio
The new firm will focus on developing CAR T-cell therapies with new co-stimulatory domains with the goal of treating solid cancers.